Celeris Therapeutics announces the appointment of biotech veterans to lead drug discovery and biology efforts

TOPICS:

Posted By: Advance February 2, 2022

Hires of Dr. Friedrich Kroll, as VP of Drug Discovery and Dr. Markus Muellner, as VP of Biology reflect ambitions to move quickly into the clinic